ATP1A2 and neoplasm: ATP1A2 inhibits the proliferation, invasion, migration, and epithelial–mesenchymal transition of prostate cancer cells by regulating the transforming growth factor-β/Smad signaling pathway, which exerts tumor-suppressing effects.14